Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-28
DOI
10.1038/s41419-022-05443-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways
- (2022) Ali Rafat et al. LIFE SCIENCES
- Structure of human telomerase holoenzyme with bound telomeric DNA
- (2021) George E. Ghanim et al. NATURE
- Regulation of human telomerase in homeostasis and disease
- (2020) Caitlin M. Roake et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity
- (2020) Soma Roy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Non-canonical functions of Telomerase Reverse Transcriptase – Impact on redox homeostasis
- (2020) Julia Rosen et al. Redox Biology
- Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in Zebrafish
- (2020) Silvia Giunco et al. Cancers
- Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
- (2019) Natalia Konieczna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death
- (2019) Rui Liu et al. Cell Death & Disease
- Combination Treatment with Imetelstat, a Telomerase Inhibitor, and Ruxolitinib Depletes Myelofibrosis Hematopoietic Stem Cells and Progenitor Cells
- (2019) Cing Siang Hu et al. BLOOD
- Transient Telomerase Inhibition with Imetelstat Impacts DNA Damage Signals and Cell-Cycle Kinetics
- (2018) Connor A.H. Thompson et al. MOLECULAR CANCER RESEARCH
- Cryo-EM structure of substrate-bound human telomerase holoenzyme
- (2018) Thi Hoang Duong Nguyen et al. NATURE
- Advances in the Discovery of Anthraquinone-Based Anticancer Agents
- (2018) Alexander S. Tikhomirov et al. Recent Patents on Anti-Cancer Drug Discovery
- MIM through MOM: the awakening of Bax and Bak pores
- (2018) Katia Cosentino et al. EMBO JOURNAL
- Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties
- (2018) Alexander S. Tikhomirov et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Telomeres in cancer: tumour suppression and genome instability
- (2017) John Maciejowski et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Computer-aided prediction and cytotoxicity evaluation of dithiocarbamates of 9,10-anthracenedione as new anticancer agents
- (2017) M. Stasevych et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- Shelterin Protects Chromosome Ends by Compacting Telomeric Chromatin
- (2016) Jigar N. Bandaria et al. CELL
- A 4:1 stoichiometric binding and stabilization of mitoxantrone-parallel stranded G-quadruplex complex established by spectroscopy techniques
- (2016) Tarikere Palakashan Pradeep et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells
- (2016) Andrea Celeghin et al. Cell Death & Disease
- TMPyP4 promotes cancer cell migration at low doses, but induces cell death at high doses
- (2016) Xiao-Hui Zheng et al. Scientific Reports
- Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX
- (2016) Yang Hu et al. Scientific Reports
- Selective recognition and stabilization of new ligands targeting the potassium form of the human telomeric G-quadruplex DNA
- (2016) Yi-Hwa Lin et al. Scientific Reports
- Telomerase reverse transcriptase in the regulation of gene expression
- (2014) Junzhi Zhou et al. BMB Reports
- Pterostilbene as a Potential Novel Telomerase Inhibitor: Molecular Docking Studies and Its in vitro Evaluation
- (2014) Radhika Tippani et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
- (2014) R. Gupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual recognition of the human telomeric G-quadruplex by a neomycin–anthraquinone conjugate
- (2013) Nihar Ranjan et al. CHEMICAL COMMUNICATIONS
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- Novel anticancer therapeutics targeting telomerase
- (2012) Maria Ruden et al. CANCER TREATMENT REVIEWS
- Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
- (2012) Jian Hu et al. CELL
- Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
- (2012) Marzia Fumagalli et al. NATURE CELL BIOLOGY
- Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence
- (2012) Graeme Hewitt et al. Nature Communications
- The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel
- (2009) E. M. Goldblatt et al. MOLECULAR CANCER THERAPEUTICS
- Targeting telomerase for cancer therapeutics
- (2008) J W Shay et al. BRITISH JOURNAL OF CANCER
- Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence
- (2008) Asako J Nakamura et al. Epigenetics & Chromatin
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started